Merck Research Laboratories preclinical data

Merck researchers and colleagues published in Nature Medicine that L-377,202, a conjugate between the chemotherapeutic doxorubicin and

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE